Areca nut contributes to oral malignancy through facilitating the conversion of cancer stem cells

Molecular Carcinogenesis

Volumn 55, Issue 5, 2016, Pages 1012-1023

  Li, Yi Chen ^a   Chang, Joseph T ^b   Chiu, Crystal ^a   Lu, Ya Ching ^a   Li, Yan Liang ^a   Chiang, Chang Hsu ^a   You, Guo Rung ^a   Lee, Li Yu ^b   Cheng, Ann Joy ^a  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

Areca nut; Cancer stem cell; Carcinogenesis; Invasion; Oral cancer

Indexed keywords

BREAST CANCER RESISTANCE PROTEIN; CD133 ANTIGEN; CD24 ANTIGEN; CISPLATIN; GLYCOPROTEIN; GLYCOPROTEIN GP 78; GLYCOPROTEIN GP 96; HERMES ANTIGEN; INTERSTITIAL COLLAGENASE; REACTIVE OXYGEN METABOLITE; TRANSCRIPTION FACTOR FOXC2; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL; TRANSCRIPTION FACTOR SOX9; UNCLASSIFIED DRUG; ABC TRANSPORTER; ABCG2 PROTEIN, HUMAN; PLANT EXTRACT; TUMOR PROTEIN;

ANTIGEN EXPRESSION; ARTICLE; BETEL NUT; CANCER CHEMOTHERAPY; CANCER INHIBITION; CANCER PREVENTION; CANCER RADIOTHERAPY; CANCER STEM CELL; CARCINOGENESIS; CELL AGING; CELL INVASION; CELL PROLIFERATION; CELL SUBPOPULATION; CONFOCAL MICROSCOPY; CYTOTOXICITY; EPITHELIAL MESENCHYMAL TRANSITION; FLOW CYTOMETRY; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; IRRADIATION; MOUTH CANCER; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; RADIOSENSITIVITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SIDE POPULATION CELL; SPHEROID CELL; UPREGULATION; ARECA; CELL MOTION; CHEMICALLY INDUCED; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; MOUTH TUMOR; PATHOLOGY; TUMOR CELL LINE;

ARECA; ATP-BINDING CASSETTE TRANSPORTERS; CELL LINE, TUMOR; CELL MOVEMENT; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOPLASTIC STEM CELLS; PLANT EXTRACTS; REACTIVE OXYGEN SPECIES; UP-REGULATION;

EID: 84931082140     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22344     Document Type: Article

References (49)

1. Secretan B, Straif K, Baan R, et al. A review of human carcinogens-Part E: Tobacco, areca nut, alcohol, coal smoke, and salted fish. Lancet Oncol 2009; 10:1033-1034.
2. Johnson NW, Warnakulasuriya S, Gupta PC, et al. Global oral health inequalities in incidence and outcomes for oral cancer: Causes and solutions. Adv Dent Res 2011; 23:237-246.
3. Saman DM. A review of the epidemiology of oral and pharyngeal carcinoma: Update. Head neck oncol 2012; 4:1.
4. Chen YJ, Chang JT, Liao CT, et al. Head and neck cancer in the betel quid chewing area: Recent advances in molecular carcinogenesis. Cancer Sci 2008; 99:1507-1514.
5. Stucken E, Weissman J, Spiegel JH. Oral cavity risk factors: Experts' opinions and literature support. Head Neck Surg 2010; 39:76-89.
6. Krishna Rao SV, Mejia G, Roberts-Thomson K, Logan R. Epidemiology of oral cancer in Asia in the past decade? an update (2000-2012). Asian Pac J Cancer P 2013; 14:5567-5577.
7. IARC Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monog Eval Carc 2004; 85:1-334.
8. Jeng JH, Hahn LJ, Lin BR, Hsieh CC, Chan CP, Chang MC. Effects of areca nut, inflorescence piper betle extracts and arecoline on cytotoxicity, total and unscheduled DNA synthesis in cultured gingival keratinocytes. J Oral Pathol Med 1999; 28:64-71.
9. Tsai YS, Lee KW, Huang JL, et al. Arecoline, a major alkaloid of areca nut, inhibits p53, represses DNA repair, and triggers DNA damage response in human epithelial cells. Toxicology 2008; 249:230-237.
10. Thangjam GS, Kondaiah P. Regulation of oxidative-stress responsive genes by arecoline in human keratinocytes. J Periodontal Res 2009; 44:673-682.
11. Chang MC, Wu HL, Lee JJ, et al. The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation. J Biol Chem 2004; 279:50676-50683.
12. Chang LY, Wan HC, Lai YL, et al. Areca nut extracts increased expression of inflammatory cytokines, tumor necrosis factor-alpha, interleukin-1beta, interleukin-6 and interleukin-8, in peripheral blood mononuclear cells. J Periodontal Res 2009; 44:175-183.
13. Chang LY, Wan HC, Lai YL, Chou IC, Chen YT, Hung SL. Areca nut extracts increased the expression of cyclooxygenase-2, prostaglandin E2 and interleukin-1alpha in human immune cells via oxidative stress. Arch Oral Biol 2013; 58:1523-1531.
14. Chen PH, Tsai CC, Lin YC, et al. Ingredients contribute to variation in production of reactive oxygen species by areca quid. J Toxicol Environ Health A 2006; 69:1055-1069.
15. Shih YT, Chen PS, Wu CH, Tseng YT, Wu YC, Lo YC. Arecoline, a major alkaloid of the areca nut, causes neurotoxicity through enhancement of oxidative stress and suppression of the antioxidant protective system. Free Radic Biol Med 2010; 49:1471-1479.
16. Yen CY, Lin MH, Liu SY, et al. Arecoline-mediated inhibition of AMP-activated protein kinase through reactive oxygen species is required for apoptosis induction. Oral Oncol 2011; 47:345-351.
17. Chen YJ, Liao CT, Chen PJ, et al. Downregulation of Ches1 and other novel genes in oral cancer cells chronically exposed to areca nut extract. Head Neck 2011; 33:257-266.
18. Kang CJ, Chen YJ, Liao CT, et al. Transcriptome profiling and network pathway analysis of genes associated with invasive phenotype in oral cancer. Cancer Lett 2009; 284:131-140.
19. Lu YC, Chen YJ, Wang HM, et al. Oncogenic function and early detection potential of miRNA-10b in oral cancer as identified by microRNA profiling. Cancer Prev Res 2012; 5:665-674.
20. Chiu CC, Lin CY, Lee LY, et al. Molecular chaperones as a common set of proteins that regulate the invasion phenotype of head and neck cancer. Clin Cancer Res 2011; 17:4629-4641.
21. Chiu CC, Lee LY, Li YC, et al. Grp78 as a therapeutic target for refractory head-neck cancer with CD24(-)CD44(+) stemness phenotype. Cancer Gene Ther 2013; 20:606-615.
22. Lin TY, Chang JT, Wang HM, et al. Proteomics of the radioresistant phenotype in head-and-neck cancer: Gp96 as a novel prediction marker and sensitizing target for radiotherapy. Int J Radiat Oncol Bio Phys 2010; 78:246-256.
23. Lin CY, Chen WH, Liao CT, et al. Positive association of glucose-regulated protein 78 during oral cancer progression and the prognostic value in oral precancerous lesions. Head Neck 2010; 32:1028-1039.
24. Chen YJ, Lee LY, Chao YK, et al. DSG3 facilitates cancer cell growth and invasion through the DSG3-plakoglobin-TCF/LEF-Myc/cyclin D1/MMP signaling pathway. PLoS ONE 2013; 8:6e64088.
25. Goodell MA, Brose K, Paradis G, Conner AS, Mulligan RC. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J Exp Med 1996; 183:1797-1806.
26. Scheel C, Weinberg RA. Cancer stem cells and epithelial-mesenchymal transition: Concepts and molecular links. Semin Cancer Biol 2012; 22:396-403.
27. Tiwari N, Gheldof A, Tatari M, Christofori G. EMT as the ultimate survival mechanism of cancer cells. Semin Cancer Biol 2012; 22:194-207.
28. Ni Z, Bikadi Z, Rosenberg MF, Mao Q. Structure and function of the human breast cancer resistance protein (BCRP/ABCG2). Curr Drug Metab 2010; 11:603-617.
29. Cortes-Wanstreet MM, Giedzinski E, Limoli CL, Luderer U. Overexpression of glutamate-cysteine ligase protects human COV434 granulosa tumour cells against oxidative and gamma-radiation-induced cell death. Mutagenesis 2009; 24:211-224.
30. Krishnamurthy S, Nor JE. Head and neck cancer stem cells. J Dent Res 2012; 91:334-340.
31. Medema JP. Cancer stem cells: the challenges ahead. Nat Cell Biol 2013; 15:338-344.
32. Sugihara E, Saya H. Complexity of cancer stem cells. Int J Cancer 2013; 132:1249-1259.
33. Hurt EM, Kawasaki BT, Klarmann GJ, Thomas SB, Farrar WL. CD44+ CD24(-) prostate cells are early cancer progenitor/stem cells that provide a model for patients with poor prognosis. Br J Cancer 2008; 98:756-765.
34. Idowu MO, Kmieciak M, Dumur C, et al. CD44(+)/CD24(-/low) cancer stem/progenitor cells are more abundant in triple-negative invasive breast carcinoma phenotype and are associated with poor outcome. Hum Pathol 2012; 43:364-373.
35. Meng E, Long B, Sullivan P, et al. CD44+/CD24- ovarian cancer cells demonstrate cancer stem cell properties and correlate to survival. Clin Exp Metastasis 2012; 29:939-948.
36. Sinha N, Mukhopadhyay S, Das DN, Panda PK, Bhutia SK. Relevance of cancer initiating/stem cells in carcinogenesis and therapy resistance in oral cancer. Oral Oncol 2013; 49:854-862.
37. Allegra E, Trapasso S. Cancer stem cells in head and neck cancer. Onco Targets Ther 2012; 5:375-383.
38. Peng CH, Liao CT, Peng SC, et al. A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. PLoS ONE 2011; 6:e23452.
39. Lin PC, Chang WH, Chen YH, Lee CC, Lin YH, Chang JG. Cytotoxic effects produced by arecoline correlated to epigenetic regulation in human K-562 cells. J Toxicol Env Heal A 2011; 74:737-745.
40. Huang LW, Hsieh BS, Cheng HL, Hu YC, Chang WT, Chang KL. Arecoline decreases interleukin-6 production and induces apoptosis and cell cycle arrest in human basal cell carcinoma cells. Toxicol Appl Pharmacol 2012; 258:199-207.
41. Tseng SK, Chang MC, Su CY, et al. Arecoline induced cell cycle arrest, apoptosis, and cytotoxicity to human endothelial cells. Clin Oral Investig 2012; 16:1267-1273.
42. Lee CC, Lin YC, Liu HE, Jan TR, Wang CC. Impairment of thymocyte function via induction of apoptosis by areca nut extract. J Immunotoxicol 2014; 11:190-196.
43. Lu SY, Chang KW, Liu CJ, et al. Ripe areca nut extract induces G1 phase arrests and senescence-associated phenotypes in normal human oral keratinocyte. Carcinogenesis 2006; 27:1273-1284.
44. Chang MC, Chan CP, Wang WT, et al. Toxicity of areca nut ingredients: activation of CHK1/CHK2, induction of cell cycle arrest, and regulation of MMP-9 and TIMPs production in SAS epithelial cells. Head Neck 2013; 35:1295-1302.
45. Liu SY, Liu YC, Huang WT, Huang GC, Chen TC, Lin MH. Up-regulation of matrix metalloproteinase-8 by betel quid extract and arecoline and its role in 2D motility. Oral Oncol 2007; 43:1026-1033.
46. Tseng YH, Chang KW, Liu CJ, Lin CY, Yang SC, Lin SC. Areca nut extract represses migration and differentiation while activating matrix metalloproteinase-9 of normal gingival epithelial cells. J Periodontal Res 2008; 43:490-499.
47. Lu HH, Chen LK, Cheng CY, Hung SL, Lin SC, Chang KW. Areca nut extract-treated gingival fibroblasts modulate the invasiveness of polymorphonuclear leukocytes via the production of MMP-2. J Oral Path Med 2009; 38:79-86.
48. Yen CY, Chiang WF, Liu SY, et al. Long-term stimulation of areca nut components results in increased chemoresistance through elevated autophagic activity. J Oral Path Med 2014; 43:91-96.
49. Liao CT, Wallace CG, Lee LY, et al. Clinical evidence of field cancerization in patients with oral cavity cancer in a betel quid chewing area. Oral Oncol 2014; 50:721-731.